Regeneron Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 3,575 | 0.1% | 4,631 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,687 | 0.1% | 4,779 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 1,826 | 0.1% | 3,479 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 5,980 | 0.2% | 9,428 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 7,068 | 0.2% | 9,922 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 13,027 | 0.3% | 12,392 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 15,529 | 0.4% | 14,775 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 14,114 | 0.3% | 14,664 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 15,894 | 0.3% | 18,097 | 12/31/2023 |
| 2023 Q3 | 11/2/2023 | 14,276 | 0.3% | 17,347 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 12,408 | 0.3% | 17,268 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 26,344 | 0.6% | 32,062 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 22,405 | 0.5% | 31,054 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 20,929 | 0.5% | 30,382 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 17,369 | 0.4% | 29,382 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 29,613 | 0.5% | 42,400 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 28,026 | 0.4% | 44,378 | 12/31/2021 |
| 2021 Q3 | 11/4/2021 | 26,857 | 0.3% | 44,378 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 24,070 | 0.3% | 43,094 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 14,325 | 0.2% | 30,277 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 15,460 | 0.2% | 32,000 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 13,244 | 0.2% | 23,660 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 11,922 | 0.3% | 19,116 | 6/30/2020 |
| 2020 Q1 | 5/8/2020 | 4,547 | 0.2% | 9,313 | 3/31/2020 |
| 2019 Q4 | 2/13/2020 | 1,807 | 0.0% | 4,813 | 12/31/2019 |